Education
About Us
Working with TipRanks
Follow Us
Equasens Société (FR:EQS)
:EQS
EQS Stock Chart & Stats
Day’s Range― - ―
52-Week Range€30.55 - €67.40
Previous CloseN/A
Volume720.00
Average Volume (3M)13.28K
Market Cap
€713.47M
Enterprise ValueN/A
Total Cash (Recent Filing)€63.33M
Total Debt (Recent Filing)€53.00M
Price to Earnings (P/E)19.7
Beta0.52
Next Earnings
Sep 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 02, 2024Dividend Yield2.65%
Share Statistics
EPS (TTM)1.27
Shares Outstanding15,174,125
10 Day Avg. Volume14,843
30 Day Avg. Volume13,280
Financial Highlights & Ratios
PEG Ratio-1.20
Price to Book (P/B)2.77
Price to Sales (P/S)0.00
P/FCF Ratio20.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€75.00Price Target Upside56.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Equasens News
---
Bulls Say, Bears Say
Bulls Say
EarningsEquasens had a strong Q1 with 5.9% organic growth, which should help the company regain some of the lost confidence from the investment community.
Market MomentumOrganic growth should accelerate, and margins expand, benefiting from improving market momentum and product launches.
UndervaluationEquasens is materially undervalued given that its momentum is set to improve in 2025, with a potential for re-rating driven by improved end-customer health, new product launches, regulatory tailwinds, and easier comparison basis.
Bears Say
Market EnvironmentEquasens saw revenue increase by 21% in Q1 on an easy comparison basis and improved market momentum as mobile terminals are now back on the market.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.20%
Mutual Funds
― Other Institutional Investors
97.20% Public Companies and
Individual Investors
EQS FAQ
What was Equasens Société’s price range in the past 12 months?
Equasens Société lowest stock price was €30.55 and its highest was €67.40 in the past 12 months.
What is Equasens Société’s market cap?
Equasens Société’s market cap is €713.47M.
When is Equasens Société’s upcoming earnings report date?
Equasens Société’s upcoming earnings report date is Sep 26, 2025 which is in 133 days.
How were Equasens Société’s earnings last quarter?
Equasens Société released its earnings results on Mar 28, 2025. The company reported €1.267 earnings per share for the quarter, beating the consensus estimate of N/A by €1.267.
Is Equasens Société overvalued?
According to Wall Street analysts Equasens Société’s price is currently Undervalued.
Does Equasens Société pay dividends?
Equasens Société pays a Annually dividend of €1.25 which represents an annual dividend yield of 2.65%. See more information on Equasens Société dividends here
What is Equasens Société’s EPS estimate?
Equasens Société’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Equasens Société have?
Equasens Société has 15,174,125 shares outstanding.
What happened to Equasens Société’s price movement after its last earnings report?
Equasens Société reported an EPS of €1.267 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.838%.
Which hedge fund is a major shareholder of Equasens Société?
Currently, no hedge funds are holding shares in FR:EQS
---
Company Description
Equasens Société
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
---
EQS Stock 12 Month Forecast
Average Price Target
€75.00
▲(56.58% Upside)
Technical Analysis
---